Oregon Public Employees Retirement Fund Has $5.35 Million Position in HCA Healthcare, Inc. (NYSE:HCA)

Oregon Public Employees Retirement Fund lowered its stake in HCA Healthcare, Inc. (NYSE:HCA) by 1.4% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 16,650 shares of the company’s stock after selling 237 shares during the quarter. Oregon Public Employees Retirement Fund’s holdings in HCA Healthcare were worth $5,349,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Vanguard Group Inc. boosted its position in shares of HCA Healthcare by 0.4% during the first quarter. Vanguard Group Inc. now owns 16,989,683 shares of the company’s stock worth $5,666,569,000 after buying an additional 60,304 shares during the period. Sanders Capital LLC grew its stake in shares of HCA Healthcare by 4.2% during the 4th quarter. Sanders Capital LLC now owns 11,404,003 shares of the company’s stock worth $3,086,836,000 after acquiring an additional 456,738 shares in the last quarter. Wellington Management Group LLP lifted its position in shares of HCA Healthcare by 1.7% in the fourth quarter. Wellington Management Group LLP now owns 10,186,129 shares of the company’s stock worth $2,757,181,000 after purchasing an additional 170,560 shares in the last quarter. Royal Bank of Canada increased its stake in HCA Healthcare by 35.7% in the 4th quarter. Royal Bank of Canada now owns 4,503,918 shares of the company’s stock valued at $1,219,121,000 after buying an additional 1,183,890 shares during the last quarter. Finally, Capital World Investors boosted its stake in shares of HCA Healthcare by 57.5% during the 1st quarter. Capital World Investors now owns 2,792,377 shares of the company’s stock worth $931,342,000 after buying an additional 1,019,750 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

HCA has been the subject of a number of analyst reports. Wells Fargo & Company raised their price target on HCA Healthcare from $315.00 to $365.00 and gave the company an “equal weight” rating in a research note on Tuesday, July 30th. Royal Bank of Canada upped their price target on shares of HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a research report on Friday, August 23rd. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of HCA Healthcare from $359.00 to $375.00 and gave the stock a “buy” rating in a research note on Friday, June 28th. UBS Group lifted their price target on HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a report on Wednesday, August 14th. Finally, Leerink Partners raised their price objective on HCA Healthcare from $367.00 to $396.00 and gave the company an “outperform” rating in a research report on Wednesday, July 24th. Five equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and three have given a strong buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $359.89.

Insider Activity at HCA Healthcare

In other news, SVP Christopher F. Wyatt sold 4,000 shares of the firm’s stock in a transaction that occurred on Monday, July 29th. The shares were sold at an average price of $360.20, for a total value of $1,440,800.00. Following the sale, the senior vice president now directly owns 40,449 shares in the company, valued at approximately $14,569,729.80. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In other news, SVP Kathleen M. Whalen sold 2,987 shares of the company’s stock in a transaction that occurred on Wednesday, July 31st. The stock was sold at an average price of $363.51, for a total value of $1,085,804.37. Following the completion of the transaction, the senior vice president now owns 9,454 shares of the company’s stock, valued at $3,436,623.54. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Christopher F. Wyatt sold 4,000 shares of the business’s stock in a transaction that occurred on Monday, July 29th. The stock was sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the sale, the senior vice president now directly owns 40,449 shares in the company, valued at $14,569,729.80. The disclosure for this sale can be found here. Insiders have sold 8,844 shares of company stock valued at $3,185,932 over the last ninety days. 1.60% of the stock is owned by corporate insiders.

HCA Healthcare Trading Down 0.4 %

Shares of HCA stock opened at $394.19 on Thursday. The stock has a 50 day simple moving average of $353.01 and a 200 day simple moving average of $334.95. HCA Healthcare, Inc. has a 1 year low of $215.96 and a 1 year high of $397.73. The company has a current ratio of 1.06, a quick ratio of 0.94 and a debt-to-equity ratio of 27.11. The stock has a market cap of $103.24 billion, a P/E ratio of 19.65, a price-to-earnings-growth ratio of 1.52 and a beta of 1.68.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, topping the consensus estimate of $4.97 by $0.53. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The business had revenue of $17.49 billion during the quarter, compared to analysts’ expectations of $17.05 billion. During the same quarter in the prior year, the business posted $4.29 earnings per share. HCA Healthcare’s revenue was up 10.3% compared to the same quarter last year. On average, research analysts predict that HCA Healthcare, Inc. will post 22.5 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, September 30th. Stockholders of record on Monday, September 16th will be issued a dividend of $0.66 per share. The ex-dividend date is Monday, September 16th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.67%. HCA Healthcare’s dividend payout ratio (DPR) is currently 13.16%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.